Cas 874367-19-8,Methyl (+/-)-trans-4-phenylpyrrolidine-3-carboxylate hydrochloride

874367-19-8

Post Buying Request

Basic information

Product Name: Methyl (+/-)-trans-4-phenylpyrrolidine-3-carboxylate hydrochloride
Synonyms: Methyl (+/-)-trans-4-phenylpyrrolidine-3-carboxylate hydrochloride
CAS NO:874367-19-8
Molecular Formula: C12H16ClNO2
Molecular Weight: 241.71394
EINECS: N/A
Product Categories: N/A
Mol File: 874367-19-8.mol

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: /
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Methyl (+/-)-trans-4-phenylpyrrolidine-3-carboxylate hydrochloride(CAS DataBase Reference)
NIST Chemistry Reference: Methyl (+/-)-trans-4-phenylpyrrolidine-3-carboxylate hydrochloride(874367-19-8)
EPA Substance Registry System: Methyl (+/-)-trans-4-phenylpyrrolidine-3-carboxylate hydrochloride(874367-19-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 874367-19-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

874367-19-8 Suppliers

Recommended suppliers

874367-19-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 874367-19-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,4,3,6 and 7 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 874367-19:
(8*8)+(7*7)+(6*4)+(5*3)+(4*6)+(3*7)+(2*1)+(1*9)=208
208 % 10 = 8
So 874367-19-8 is a valid CAS Registry Number.

874367-19-8Upstream product

874367-19-8Downstream Products

874367-19-8Relevant academic research and scientific papers

COMPOUNDS AS MODULATORS OF ROR GAMMA

-

Page/Page column 42, (2018/07/05)

The present invention encompasses compounds of the formula (I) wherein the variables are defined herein which are suitable for the modulation of RORγ and the treatment of diseases related to the modulation of RORγ. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 874367-19-8